Global Cellular Tumor Antigen p53 Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cellular Tumor Antigen p53 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cellular Tumor Antigen p53 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cellular Tumor Antigen p53 by Country/Region, 2017, 2022 & 2028

2.2 Cellular Tumor Antigen p53 Segment by Type

2.2.1 COTI-2

2.2.2 D-12PGJ3

2.2.3 APR-246

2.2.4 ATRN-502

2.2.5 Cenersen Sodium

2.2.6 MJ-05

2.2.7 MX-225

2.2.8 Others

2.3 Cellular Tumor Antigen p53 Sales by Type

2.3.1 Global Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2022)

2.3.2 Global Cellular Tumor Antigen p53 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cellular Tumor Antigen p53 Sale Price by Type (2017-2022)

2.4 Cellular Tumor Antigen p53 Segment by Application

2.4.1 Ovarian Cancer

2.4.2 Prostate Cancer

2.4.3 Brain Cancer

2.4.4 Others

2.5 Cellular Tumor Antigen p53 Sales by Application

2.5.1 Global Cellular Tumor Antigen p53 Sale Market Share by Application (2017-2022)

2.5.2 Global Cellular Tumor Antigen p53 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cellular Tumor Antigen p53 Sale Price by Application (2017-2022)

3 Global Cellular Tumor Antigen p53 by Company

3.1 Global Cellular Tumor Antigen p53 Breakdown Data by Company

3.1.1 Global Cellular Tumor Antigen p53 Annual Sales by Company (2020-2022)

3.1.2 Global Cellular Tumor Antigen p53 Sales Market Share by Company (2020-2022)

3.2 Global Cellular Tumor Antigen p53 Annual Revenue by Company (2020-2022)

3.2.1 Global Cellular Tumor Antigen p53 Revenue by Company (2020-2022)

3.2.2 Global Cellular Tumor Antigen p53 Revenue Market Share by Company (2020-2022)

3.3 Global Cellular Tumor Antigen p53 Sale Price by Company

3.4 Key Manufacturers Cellular Tumor Antigen p53 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cellular Tumor Antigen p53 Product Location Distribution

3.4.2 Players Cellular Tumor Antigen p53 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cellular Tumor Antigen p53 by Geographic Region

4.1 World Historic Cellular Tumor Antigen p53 Market Size by Geographic Region (2017-2022)

4.1.1 Global Cellular Tumor Antigen p53 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cellular Tumor Antigen p53 Annual Revenue by Geographic Region

4.2 World Historic Cellular Tumor Antigen p53 Market Size by Country/Region (2017-2022)

4.2.1 Global Cellular Tumor Antigen p53 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cellular Tumor Antigen p53 Annual Revenue by Country/Region

4.3 Americas Cellular Tumor Antigen p53 Sales Growth

4.4 APAC Cellular Tumor Antigen p53 Sales Growth

4.5 Europe Cellular Tumor Antigen p53 Sales Growth

4.6 Middle East & Africa Cellular Tumor Antigen p53 Sales Growth

5 Americas

5.1 Americas Cellular Tumor Antigen p53 Sales by Country

5.1.1 Americas Cellular Tumor Antigen p53 Sales by Country (2017-2022)

5.1.2 Americas Cellular Tumor Antigen p53 Revenue by Country (2017-2022)

5.2 Americas Cellular Tumor Antigen p53 Sales by Type

5.3 Americas Cellular Tumor Antigen p53 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cellular Tumor Antigen p53 Sales by Region

6.1.1 APAC Cellular Tumor Antigen p53 Sales by Region (2017-2022)

6.1.2 APAC Cellular Tumor Antigen p53 Revenue by Region (2017-2022)

6.2 APAC Cellular Tumor Antigen p53 Sales by Type

6.3 APAC Cellular Tumor Antigen p53 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cellular Tumor Antigen p53 by Country

7.1.1 Europe Cellular Tumor Antigen p53 Sales by Country (2017-2022)

7.1.2 Europe Cellular Tumor Antigen p53 Revenue by Country (2017-2022)

7.2 Europe Cellular Tumor Antigen p53 Sales by Type

7.3 Europe Cellular Tumor Antigen p53 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cellular Tumor Antigen p53 by Country

8.1.1 Middle East & Africa Cellular Tumor Antigen p53 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cellular Tumor Antigen p53 Revenue by Country (2017-2022)

8.2 Middle East & Africa Cellular Tumor Antigen p53 Sales by Type

8.3 Middle East & Africa Cellular Tumor Antigen p53 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cellular Tumor Antigen p53

10.3 Manufacturing Process Analysis of Cellular Tumor Antigen p53

10.4 Industry Chain Structure of Cellular Tumor Antigen p53

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cellular Tumor Antigen p53 Distributors

11.3 Cellular Tumor Antigen p53 Customer

12 World Forecast Review for Cellular Tumor Antigen p53 by Geographic Region

12.1 Global Cellular Tumor Antigen p53 Market Size Forecast by Region

12.1.1 Global Cellular Tumor Antigen p53 Forecast by Region (2023-2028)

12.1.2 Global Cellular Tumor Antigen p53 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cellular Tumor Antigen p53 Forecast by Type

12.7 Global Cellular Tumor Antigen p53 Forecast by Application

13 Key Players Analysis

13.1 Advaxis, Inc.

13.1.1 Advaxis, Inc. Company Information

13.1.2 Advaxis, Inc. Cellular Tumor Antigen p53 Product Offered

13.1.3 Advaxis, Inc. Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Advaxis, Inc. Main Business Overview

13.1.5 Advaxis, Inc. Latest Developments

13.2 American Gene Technologies International Inc.

13.2.1 American Gene Technologies International Inc. Company Information

13.2.2 American Gene Technologies International Inc. Cellular Tumor Antigen p53 Product Offered

13.2.3 American Gene Technologies International Inc. Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 American Gene Technologies International Inc. Main Business Overview

13.2.5 American Gene Technologies International Inc. Latest Developments

13.3 Aprea AB

13.3.1 Aprea AB Company Information

13.3.2 Aprea AB Cellular Tumor Antigen p53 Product Offered

13.3.3 Aprea AB Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Aprea AB Main Business Overview

13.3.5 Aprea AB Latest Developments

13.4 Cellceutix Corporation

13.4.1 Cellceutix Corporation Company Information

13.4.2 Cellceutix Corporation Cellular Tumor Antigen p53 Product Offered

13.4.3 Cellceutix Corporation Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cellceutix Corporation Main Business Overview

13.4.5 Cellceutix Corporation Latest Developments

13.5 Critical Outcome Technologies Inc.

13.5.1 Critical Outcome Technologies Inc. Company Information

13.5.2 Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Product Offered

13.5.3 Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Critical Outcome Technologies Inc. Main Business Overview

13.5.5 Critical Outcome Technologies Inc. Latest Developments

13.6 Eleos Inc.

13.6.1 Eleos Inc. Company Information

13.6.2 Eleos Inc. Cellular Tumor Antigen p53 Product Offered

13.6.3 Eleos Inc. Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eleos Inc. Main Business Overview

13.6.5 Eleos Inc. Latest Developments

13.7 ORCA Therapeutics B.V.

13.7.1 ORCA Therapeutics B.V. Company Information

13.7.2 ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Product Offered

13.7.3 ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 ORCA Therapeutics B.V. Main Business Overview

13.7.5 ORCA Therapeutics B.V. Latest Developments

13.8 OSE Pharma SA

13.8.1 OSE Pharma SA Company Information

13.8.2 OSE Pharma SA Cellular Tumor Antigen p53 Product Offered

13.8.3 OSE Pharma SA Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 OSE Pharma SA Main Business Overview

13.8.5 OSE Pharma SA Latest Developments

13.9 PCI Biotech Holding ASA

13.9.1 PCI Biotech Holding ASA Company Information

13.9.2 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Product Offered

13.9.3 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 PCI Biotech Holding ASA Main Business Overview

13.9.5 PCI Biotech Holding ASA Latest Developments

13.10 Quark Pharmaceuticals, Inc.

13.10.1 Quark Pharmaceuticals, Inc. Company Information

13.10.2 Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Product Offered

13.10.3 Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Quark Pharmaceuticals, Inc. Main Business Overview

13.10.5 Quark Pharmaceuticals, Inc. Latest Developments

13.11 Stemline Therapeutics, Inc.

13.11.1 Stemline Therapeutics, Inc. Company Information

13.11.2 Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Product Offered

13.11.3 Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Stemline Therapeutics, Inc. Main Business Overview

13.11.5 Stemline Therapeutics, Inc. Latest Developments

13.12 Shenzen SiBiono GeneTech Co., Ltd.

13.12.1 Shenzen SiBiono GeneTech Co., Ltd. Company Information

13.12.2 Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Product Offered

13.12.3 Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Shenzen SiBiono GeneTech Co., Ltd. Main Business Overview

13.12.5 Shenzen SiBiono GeneTech Co., Ltd. Latest Developments

13.13 SK Biopharmaceuticals Co., Ltd.

13.13.1 SK Biopharmaceuticals Co., Ltd. Company Information

13.13.2 SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Product Offered

13.13.3 SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 SK Biopharmaceuticals Co., Ltd. Main Business Overview

13.13.5 SK Biopharmaceuticals Co., Ltd. Latest Developments

13.14 Tara Immuno-Oncology Therapeutics LLC

13.14.1 Tara Immuno-Oncology Therapeutics LLC Company Information

13.14.2 Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Product Offered

13.14.3 Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Tara Immuno-Oncology Therapeutics LLC Main Business Overview

13.14.5 Tara Immuno-Oncology Therapeutics LLC Latest Developments

13.15 Z53 Therapeutics, LLC

13.15.1 Z53 Therapeutics, LLC Company Information

13.15.2 Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Product Offered

13.15.3 Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Z53 Therapeutics, LLC Main Business Overview

13.15.5 Z53 Therapeutics, LLC Latest Developments

14 Research Findings and Conclusion

Table 1. Cellular Tumor Antigen p53 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cellular Tumor Antigen p53 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of COTI-2

Table 4. Major Players of D-12PGJ3

Table 5. Major Players of APR-246

Table 6. Major Players of ATRN-502

Table 7. Major Players of Cenersen Sodium

Table 8. Major Players of MJ-05

Table 9. Major Players of MX-225

Table 10. Major Players of Others

Table 11. Global Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)

Table 12. Global Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2022)

Table 13. Global Cellular Tumor Antigen p53 Revenue by Type (2017-2022) & ($ million)

Table 14. Global Cellular Tumor Antigen p53 Revenue Market Share by Type (2017-2022)

Table 15. Global Cellular Tumor Antigen p53 Sale Price by Type (2017-2022) & (USD/Pcs)

Table 16. Global Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)

Table 17. Global Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2022)

Table 18. Global Cellular Tumor Antigen p53 Revenue by Application (2017-2022)

Table 19. Global Cellular Tumor Antigen p53 Revenue Market Share by Application (2017-2022)

Table 20. Global Cellular Tumor Antigen p53 Sale Price by Application (2017-2022) & (USD/Pcs)

Table 21. Global Cellular Tumor Antigen p53 Sales by Company (2020-2022) & (K Pcs)

Table 22. Global Cellular Tumor Antigen p53 Sales Market Share by Company (2020-2022)

Table 23. Global Cellular Tumor Antigen p53 Revenue by Company (2020-2022) ($ Millions)

Table 24. Global Cellular Tumor Antigen p53 Revenue Market Share by Company (2020-2022)

Table 25. Global Cellular Tumor Antigen p53 Sale Price by Company (2020-2022) & (USD/Pcs)

Table 26. Key Manufacturers Cellular Tumor Antigen p53 Producing Area Distribution and Sales Area

Table 27. Players Cellular Tumor Antigen p53 Products Offered

Table 28. Cellular Tumor Antigen p53 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 29. New Products and Potential Entrants

Table 30. Mergers & Acquisitions, Expansion

Table 31. Global Cellular Tumor Antigen p53 Sales by Geographic Region (2017-2022) & (K Pcs)

Table 32. Global Cellular Tumor Antigen p53 Sales Market Share Geographic Region (2017-2022)

Table 33. Global Cellular Tumor Antigen p53 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 34. Global Cellular Tumor Antigen p53 Revenue Market Share by Geographic Region (2017-2022)

Table 35. Global Cellular Tumor Antigen p53 Sales by Country/Region (2017-2022) & (K Pcs)

Table 36. Global Cellular Tumor Antigen p53 Sales Market Share by Country/Region (2017-2022)

Table 37. Global Cellular Tumor Antigen p53 Revenue by Country/Region (2017-2022) & ($ millions)

Table 38. Global Cellular Tumor Antigen p53 Revenue Market Share by Country/Region (2017-2022)

Table 39. Americas Cellular Tumor Antigen p53 Sales by Country (2017-2022) & (K Pcs)

Table 40. Americas Cellular Tumor Antigen p53 Sales Market Share by Country (2017-2022)

Table 41. Americas Cellular Tumor Antigen p53 Revenue by Country (2017-2022) & ($ Millions)

Table 42. Americas Cellular Tumor Antigen p53 Revenue Market Share by Country (2017-2022)

Table 43. Americas Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)

Table 44. Americas Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2022)

Table 45. Americas Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)

Table 46. Americas Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2022)

Table 47. APAC Cellular Tumor Antigen p53 Sales by Region (2017-2022) & (K Pcs)

Table 48. APAC Cellular Tumor Antigen p53 Sales Market Share by Region (2017-2022)

Table 49. APAC Cellular Tumor Antigen p53 Revenue by Region (2017-2022) & ($ Millions)

Table 50. APAC Cellular Tumor Antigen p53 Revenue Market Share by Region (2017-2022)

Table 51. APAC Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)

Table 52. APAC Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2022)

Table 53. APAC Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)

Table 54. APAC Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2022)

Table 55. Europe Cellular Tumor Antigen p53 Sales by Country (2017-2022) & (K Pcs)

Table 56. Europe Cellular Tumor Antigen p53 Sales Market Share by Country (2017-2022)

Table 57. Europe Cellular Tumor Antigen p53 Revenue by Country (2017-2022) & ($ Millions)

Table 58. Europe Cellular Tumor Antigen p53 Revenue Market Share by Country (2017-2022)

Table 59. Europe Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)

Table 60. Europe Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2022)

Table 61. Europe Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)

Table 62. Europe Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2022)

Table 63. Middle East & Africa Cellular Tumor Antigen p53 Sales by Country (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Cellular Tumor Antigen p53 Sales Market Share by Country (2017-2022)

Table 65. Middle East & Africa Cellular Tumor Antigen p53 Revenue by Country (2017-2022) & ($ Millions)

Table 66. Middle East & Africa Cellular Tumor Antigen p53 Revenue Market Share by Country (2017-2022)

Table 67. Middle East & Africa Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2022)

Table 69. Middle East & Africa Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)

Table 70. Middle East & Africa Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2022)

Table 71. Key Market Drivers & Growth Opportunities of Cellular Tumor Antigen p53

Table 72. Key Market Challenges & Risks of Cellular Tumor Antigen p53

Table 73. Key Industry Trends of Cellular Tumor Antigen p53

Table 74. Cellular Tumor Antigen p53 Raw Material

Table 75. Key Suppliers of Raw Materials

Table 76. Cellular Tumor Antigen p53 Distributors List

Table 77. Cellular Tumor Antigen p53 Customer List

Table 78. Global Cellular Tumor Antigen p53 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. Global Cellular Tumor Antigen p53 Sales Market Forecast by Region

Table 80. Global Cellular Tumor Antigen p53 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Global Cellular Tumor Antigen p53 Revenue Market Share Forecast by Region (2023-2028)

Table 82. Americas Cellular Tumor Antigen p53 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Americas Cellular Tumor Antigen p53 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. APAC Cellular Tumor Antigen p53 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 85. APAC Cellular Tumor Antigen p53 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 86. Europe Cellular Tumor Antigen p53 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Europe Cellular Tumor Antigen p53 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Middle East & Africa Cellular Tumor Antigen p53 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 89. Middle East & Africa Cellular Tumor Antigen p53 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Global Cellular Tumor Antigen p53 Sales Forecast by Type (2023-2028) & (K Pcs)

Table 91. Global Cellular Tumor Antigen p53 Sales Market Share Forecast by Type (2023-2028)

Table 92. Global Cellular Tumor Antigen p53 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 93. Global Cellular Tumor Antigen p53 Revenue Market Share Forecast by Type (2023-2028)

Table 94. Global Cellular Tumor Antigen p53 Sales Forecast by Application (2023-2028) & (K Pcs)

Table 95. Global Cellular Tumor Antigen p53 Sales Market Share Forecast by Application (2023-2028)

Table 96. Global Cellular Tumor Antigen p53 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 97. Global Cellular Tumor Antigen p53 Revenue Market Share Forecast by Application (2023-2028)

Table 98. Advaxis, Inc. Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 99. Advaxis, Inc. Cellular Tumor Antigen p53 Product Offered

Table 100. Advaxis, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Advaxis, Inc. Main Business

Table 102. Advaxis, Inc. Latest Developments

Table 103. American Gene Technologies International Inc. Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 104. American Gene Technologies International Inc. Cellular Tumor Antigen p53 Product Offered

Table 105. American Gene Technologies International Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. American Gene Technologies International Inc. Main Business

Table 107. American Gene Technologies International Inc. Latest Developments

Table 108. Aprea AB Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 109. Aprea AB Cellular Tumor Antigen p53 Product Offered

Table 110. Aprea AB Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Aprea AB Main Business

Table 112. Aprea AB Latest Developments

Table 113. Cellceutix Corporation Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 114. Cellceutix Corporation Cellular Tumor Antigen p53 Product Offered

Table 115. Cellceutix Corporation Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. Cellceutix Corporation Main Business

Table 117. Cellceutix Corporation Latest Developments

Table 118. Critical Outcome Technologies Inc. Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 119. Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Product Offered

Table 120. Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. Critical Outcome Technologies Inc. Main Business

Table 122. Critical Outcome Technologies Inc. Latest Developments

Table 123. Eleos Inc. Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 124. Eleos Inc. Cellular Tumor Antigen p53 Product Offered

Table 125. Eleos Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Eleos Inc. Main Business

Table 127. Eleos Inc. Latest Developments

Table 128. ORCA Therapeutics B.V. Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 129. ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Product Offered

Table 130. ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. ORCA Therapeutics B.V. Main Business

Table 132. ORCA Therapeutics B.V. Latest Developments

Table 133. OSE Pharma SA Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 134. OSE Pharma SA Cellular Tumor Antigen p53 Product Offered

Table 135. OSE Pharma SA Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 136. OSE Pharma SA Main Business

Table 137. OSE Pharma SA Latest Developments

Table 138. PCI Biotech Holding ASA Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 139. PCI Biotech Holding ASA Cellular Tumor Antigen p53 Product Offered

Table 140. PCI Biotech Holding ASA Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 141. PCI Biotech Holding ASA Main Business

Table 142. PCI Biotech Holding ASA Latest Developments

Table 143. Quark Pharmaceuticals, Inc. Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 144. Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Product Offered

Table 145. Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 146. Quark Pharmaceuticals, Inc. Main Business

Table 147. Quark Pharmaceuticals, Inc. Latest Developments

Table 148. Stemline Therapeutics, Inc. Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 149. Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Product Offered

Table 150. Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 151. Stemline Therapeutics, Inc. Main Business

Table 152. Stemline Therapeutics, Inc. Latest Developments

Table 153. Shenzen SiBiono GeneTech Co., Ltd. Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 154. Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Product Offered

Table 155. Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 156. Shenzen SiBiono GeneTech Co., Ltd. Main Business

Table 157. Shenzen SiBiono GeneTech Co., Ltd. Latest Developments

Table 158. SK Biopharmaceuticals Co., Ltd. Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 159. SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Product Offered

Table 160. SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 161. SK Biopharmaceuticals Co., Ltd. Main Business

Table 162. SK Biopharmaceuticals Co., Ltd. Latest Developments

Table 163. Tara Immuno-Oncology Therapeutics LLC Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 164. Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Product Offered

Table 165. Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 166. Tara Immuno-Oncology Therapeutics LLC Main Business

Table 167. Tara Immuno-Oncology Therapeutics LLC Latest Developments

Table 168. Z53 Therapeutics, LLC Basic Information, Cellular Tumor Antigen p53 Manufacturing Base, Sales Area and Its Competitors

Table 169. Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Product Offered

Table 170. Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 171. Z53 Therapeutics, LLC Main Business

Table 172. Z53 Therapeutics, LLC Latest Developments

List of Figures

Figure 1. Picture of Cellular Tumor Antigen p53

Figure 2. Cellular Tumor Antigen p53 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cellular Tumor Antigen p53 Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Cellular Tumor Antigen p53 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cellular Tumor Antigen p53 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of COTI-2

Figure 10. Product Picture of D-12PGJ3

Figure 11. Product Picture of APR-246

Figure 12. Product Picture of ATRN-502

Figure 13. Product Picture of Cenersen Sodium

Figure 14. Product Picture of MJ-05

Figure 15. Product Picture of MX-225

Figure 16. Product Picture of Others

Figure 17. Global Cellular Tumor Antigen p53 Sales Market Share by Type in 2021

Figure 18. Global Cellular Tumor Antigen p53 Revenue Market Share by Type (2017-2022)

Figure 19. Cellular Tumor Antigen p53 Consumed in Ovarian Cancer

Figure 20. Global Cellular Tumor Antigen p53 Market: Ovarian Cancer (2017-2022) & (K Pcs)

Figure 21. Cellular Tumor Antigen p53 Consumed in Prostate Cancer

Figure 22. Global Cellular Tumor Antigen p53 Market: Prostate Cancer (2017-2022) & (K Pcs)

Figure 23. Cellular Tumor Antigen p53 Consumed in Brain Cancer

Figure 24. Global Cellular Tumor Antigen p53 Market: Brain Cancer (2017-2022) & (K Pcs)

Figure 25. Cellular Tumor Antigen p53 Consumed in Others

Figure 26. Global Cellular Tumor Antigen p53 Market: Others (2017-2022) & (K Pcs)

Figure 27. Global Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2022)

Figure 28. Global Cellular Tumor Antigen p53 Revenue Market Share by Application in 2021

Figure 29. Cellular Tumor Antigen p53 Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Cellular Tumor Antigen p53 Revenue Market Share by Company in 2021

Figure 31. Global Cellular Tumor Antigen p53 Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Cellular Tumor Antigen p53 Revenue Market Share by Geographic Region in 2021

Figure 33. Global Cellular Tumor Antigen p53 Sales Market Share by Region (2017-2022)

Figure 34. Global Cellular Tumor Antigen p53 Revenue Market Share by Country/Region in 2021

Figure 35. Americas Cellular Tumor Antigen p53 Sales 2017-2022 (K Pcs)

Figure 36. Americas Cellular Tumor Antigen p53 Revenue 2017-2022 ($ Millions)

Figure 37. APAC Cellular Tumor Antigen p53 Sales 2017-2022 (K Pcs)

Figure 38. APAC Cellular Tumor Antigen p53 Revenue 2017-2022 ($ Millions)

Figure 39. Europe Cellular Tumor Antigen p53 Sales 2017-2022 (K Pcs)

Figure 40. Europe Cellular Tumor Antigen p53 Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Cellular Tumor Antigen p53 Sales 2017-2022 (K Pcs)

Figure 42. Middle East & Africa Cellular Tumor Antigen p53 Revenue 2017-2022 ($ Millions)

Figure 43. Americas Cellular Tumor Antigen p53 Sales Market Share by Country in 2021

Figure 44. Americas Cellular Tumor Antigen p53 Revenue Market Share by Country in 2021

Figure 45. United States Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Cellular Tumor Antigen p53 Sales Market Share by Region in 2021

Figure 50. APAC Cellular Tumor Antigen p53 Revenue Market Share by Regions in 2021

Figure 51. China Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Cellular Tumor Antigen p53 Sales Market Share by Country in 2021

Figure 58. Europe Cellular Tumor Antigen p53 Revenue Market Share by Country in 2021

Figure 59. Germany Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Cellular Tumor Antigen p53 Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Cellular Tumor Antigen p53 Revenue Market Share by Country in 2021

Figure 66. Egypt Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Cellular Tumor Antigen p53 Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Cellular Tumor Antigen p53 in 2021

Figure 72. Manufacturing Process Analysis of Cellular Tumor Antigen p53

Figure 73. Industry Chain Structure of Cellular Tumor Antigen p53

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles